ro's glp-1 supply tracker Ro launches to help patients navigate shortages Most of the conversation around

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Kentucky is suing prediction markets Kalshi and Polymarket as well as casino-style online game company VGW.

GLP-1

They work by mimicking natural hormones that control appetite and blood sugar,

Here is how to track where you are and close the gap.

Real-world semaglutide and tirzepatide results from Glapp tracking app.